Evidence map›Paper›PMID 30178911›Full record

ArticleHIV medicine2019

Recurrence after hospitalization for acute coronary syndrome among HIV-infected and HIV-uninfected individuals.

J L Marcus, L B Hurley, A Prasad, J Zaroff, D B Klein, M A Horberg, A S Go, G N DeLorenze, C P Quesenberry, S Sidney and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in HIV medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

J L MarcusHarvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA.ORCID 0000-0002-8552-414X
L B HurleyKaiser Permanente Division of Research, Oakland, CA.
A PrasadKaiser Permanente San Francisco Medical Center, San Francisco, CA.
J ZaroffKaiser Permanente San Francisco Medical Center, San Francisco, CA.
D B KleinKaiser Permanente San Leandro Medical Center, San Leandro, CA.
M A HorbergKaiser Permanente Mid-Atlantic Permanente Research Institute, Rockville, MD, USA.
A S GoKaiser Permanente Division of Research, Oakland, CA.
G N DeLorenzeKaiser Permanente Division of Research, Oakland, CA.
C P QuesenberryKaiser Permanente Division of Research, Oakland, CA.
S SidneyKaiser Permanente Division of Research, Oakland, CA.
J C LoKaiser Permanente Division of Research, Oakland, CA.ORCID 0000-0001-8718-2561
M J SilverbergKaiser Permanente Division of Research, Oakland, CA.ORCID 0000-0001-9322-1395
Kaiser Permanente · USKaiser Permanente San Francisco Medical Center · USHarvard University · USKaiser Permanente San Leandro Medical Center · US

Funding

Optimizing Care for HIV/HCV-Coinfected Patients in the New HCV Treatment EraK01AI122853 · NIAID · KAISER FOUNDATION RESEARCH INSTITUTE · PI MARCUS, JULIA L. · 2016 to 2020
$655k
Kaiser PermanenteNational Institute of Allergy and Infectious Diseases K01 122853NIAID NIH HHS K01 AI122853
6 · The paper itself

Abstract

objectivesWe evaluated the association of HIV infection and immunodeficiency with acute coronary syndrome (ACS) recurrence, and with all-cause mortality as a secondary outcome, after hospitalization for ACS among HIV-infected and HIV-uninfected individuals.

methodsWe conducted a retrospective cohort study within Kaiser Permanente Northern California of HIV-infected and HIV-uninfected adults discharged after ACS hospitalization [types: ST-elevation myocardial infarction (STEMI), non-STEMI, or unstable angina] during 1996-2010. We compared the outcomes of ACS recurrence and all-cause mortality within 3 years, both overall by HIV status and stratified by recent CD4 count, with HIV-uninfected individuals as the reference group. Hazard ratios (HRs) were obtained from Cox regression models with adjustment for age, sex, race/ethnicity, year, ACS type, smoking, and cardiovascular risk factors.

resultsAmong 226 HIV-infected and 86 321 HIV-uninfected individuals with ACS, HIV-infected individuals had a similar risk of ACS recurrence compared with HIV-uninfected individuals [HR 1.08; 95% confidence interval (CI) 0.76-1.54]. HIV infection was independently associated with all-cause mortality after ACS hospitalization overall (HR 2.52; 95% CI 1.81-3.52). In CD4-stratified models, post-ACS mortality was higher for HIV-infected individuals with CD4 counts of 201-499 cells/μL (HR 2.64; 95% CI 1.66-4.20) and < 200 cells/μL (HR 5.41; 95% CI 3.14-9.34), but not those with CD4 counts ≥ 500 cells/μL (HR 0.67; 95% CI 0.22-2.08), compared with HIV-uninfected individuals (P trend < 0.001).

conclusionsHIV infection and immunodeficiency were not associated with recurrence of ACS after hospitalization. All-cause mortality was higher among HIV-infected compared with HIV-uninfected individuals, but there was no excess mortality risk among HIV-infected individuals with high CD4 counts.

Indexed as

Acute Coronary SyndromeCase-Control StudiesCause of DeathCD4 Lymphocyte CountFemaleHIV InfectionsHospitalizationHumansLogistic ModelsMaleRecurrenceRetrospective Studiesacute coronary syndromecardiovascular diseasesCD4 lymphocyte countHIVmyocardial infarction

Identifiers

PMID30178911
PMCPMC6309474
OpenAlexW2891351712

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.